thalidomide has been researched along with Anti-Phospholipid Antibody Syndrome in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tektonidou, MG | 1 |
Vlachoyiannopoulos, PG | 1 |
Pagnoux, C | 1 |
Lutz-Zarrouk, V | 1 |
Michel, M | 1 |
Schaeffer, A | 1 |
Godeau, B | 1 |
2 other studies available for thalidomide and Anti-Phospholipid Antibody Syndrome
Article | Year |
---|---|
Antiphospholipid syndrome triggered by thalidomide in a patient with discoid lupus erythematosus.
Topics: Adult; Antiphospholipid Syndrome; Humans; Immunosuppressive Agents; Lupus Erythematosus, Discoid; Ma | 2003 |
Cerebral venous thrombosis in a patient with antiphospholipid syndrome treated with thalidomide.
Topics: Aged; Anticoagulants; Antiphospholipid Syndrome; Humans; Immunosuppressive Agents; International Nor | 2004 |